U.S. Interventional Radiology Market by Product (MRI System, Ultrasound Imaging System, CT Scanner, Angiography System, Fluoroscopy System, and Biopsy System), Procedure (Angiography, Balloon Angioplasty, Embolization, Biopsy, Vertebroplasty–Kyphoplasty, and RF Ablation), Application (Oncology, Cardiology, Urology & Nephrology, and Gastroenterology), and End User (Hospitals, Catheterization Labs, and Ambulatory Surgical Centers): Opportunity Analysis and Industry Forecast, 2019–2026

Medical Devices & Supplies	LI_184873	Pages: NA	Dec 2019 \| 529 Views
Author(s) : NA	Tables: NA	Charts: NA	Formats*:

U.S. Interventional Radiology Market Outlook:

Interventional radiology is a technique that provides minimally invasive image-guided diagnosis and treatment. It is widely performed for both diagnostic and therapeutic procedures and uses radiological image guidance such as intra-vascular ultrasound, X-ray fluoroscopy, ultrasound, computed tomography (CT), or magnetic resonance imaging (MRI). Interventional radiology techniques guide catheters and other small instruments inside the body and diagnose the site of concern to treat a variety of medical disorders without invasive surgery. In addition, interventional radiology reduces pain, risk, and recovery time in comparison to open surgery owing to its less invasive nature, and thus is increasingly being used for various disease diagnosis. The essential skills required for the interventional radiologist are in diagnostic image interpretation, operation of needles, and the use of fine catheter tubes & wires to navigate around the body under imaging control.

The U.S. interventional radiology market is expected to witness significant growth during the forecast period due to factors such as increase in preference for minimally invasive imaging guided procedures and rise in prevalence of chronic diseases such as cancer, blood vessel diseases, and others. In addition, introduction of novel technologies such as fractional flow reserve, thrombectomy technologies, and intra-vascular ultrasound technology is expected to drive the growth of the U.S interventional radiology market. However, implementation of stringent regulatory procedures for approval of interventional radiology devices and their high cost are the major factors anticipated to restrain the market growth. On the contrary, recent advancements and increase in applications & launches of interventional radiology accessories in the U.S. are projected to offer remunerative opportunities for market expansion during the forecast period. For instance, Philips launched a new IntraSight interventional application-based platform, which offers the fractional flow reserve (FFR) and intravascular ultrasound (IVUS) for image-guided treatments of the heart and peripheral blood vessels. In addition, Embolx received an FDA approval for the next-generation sniper balloon occlusion microcatheter, which is available in three lengths 110, 130, and 150 cm and enables the advanced navigation through radial arterial access and complex vascular structures. Furthermore, ion endoluminal system provided by the Intuitive Surgical Inc. received the U.S. Food and Drug Administration (FDA) clearance that enables minimally invasive biopsy in peripheral lung.

The U.S. interventional-radiology market is segmented into product, procedure, application, and end user. On the basis of product, the market is categorized into MRI system ultrasound imaging system, CT scanner, angiography system, fluoroscopy system, and biopsy system. By procedure, it is divided into angiography, balloon angioplasty, embolization, biopsy, vertebroplasty–kyphoplasty, and RF ablation. The applications covered in the study include oncology, cardiology, urology & nephrology, and gastroenterology. Depending on end user, the market is fragmented into hospitals, catheterization labs, and ambulatory surgical centers.

The key players operating in the U.S. interventional-radiology market include GENERAL ELECTRIC, Koninklijke Philips N.V., Canon Medical Systems Corporation, Hitachi Medical Corporation, Carestream Health, Esaote SpA, Hologic, Inc., Shimadzu Corporation and Samsung Medison Co., Ltd., and Siemens Healthcare Diagnostics, Inc. Other players profiled in the report are Embolx, Inc., Cardinal Health, B. Braun Melsungen AG, BD, Stryker, and Cook.

KEY BENEFITS FOR STAKEHOLDERS

This report provides a detailed quantitative analysis of the current interventional radiology market trends and future estimations from 2019 to 2026, which assist to identify the prevailing opportunities.
A comprehensive analysis of the factors that drive and restrain the growth of the global interventional radiology market is provided.
Region-wise and country-wise market conditions are comprehensively analyzed in this report.
An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.

KEY MARKET SEGMENTS

By Product

MRI System
Ultrasound Imaging System
CT Scanner
Angiography System
Fluoroscopy System
Biopsy System

By Procedure

Angiography
Balloon Angioplasty
Embolization
Biopsy
Vertebroplasty-Kyphoplasty
RF Ablation

By Application

Oncology
Cardiology
Urology & Nephrology
Gastroenterology

By End User

Hospitals
Catheterization Labs
Ambulatory Surgical centers

CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. TOP WINNING STRATEGIES
3.3. MARKET SHARE ANALYSIS/TOP PLAYER POSITIONING, 2017
3.4. MARKET DYNAMICS
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
3.5. CPT CODES
3.5.1. CPT codes to insurance company
3.5.2. Procedures to CPT codes
3.6. INTERVENTIONAL RADIOLOGY PROCEDURES IN DALLAS

CHAPTER 4 U.S. INTERVENTIONAL RADIOLOGY MARKET, BY STATE

4.1. TEXAS
4.1.1. Market size and forecast
4.2. REST OF THE U.S.
4.2.1. Market size and forecast

CHAPTER 5 COMPANY PROFILES

5.1. GENERAL ELECTRIC COMPANY
5.1.1. Operating business segments
5.1.2. Business performance
5.1.3. Key strategic moves and developments
5.2. SIEMENS AG
5.2.1. Operating business segments
5.2.2. Business performance
5.2.3. Key strategic moves and developments
5.3. KONINKLIJKE PHILIPS N.V.
5.3.1. Operating business segments
5.3.2. Business performance
5.3.3. Key strategic moves and developments
5.4. TOSHIBA MEDICAL SYSTEMS CORPORATION (TOSHIBA CORPORATION)
5.4.1. Operating business segments
5.4.2. Business performance
5.4.3. Key strategic moves and developments
5.5. HITACHI MEDICAL CORPORATION (HITACHI LTD.)
5.5.1. Operating business segments
5.5.2. Business performance
5.5.3. Key strategic moves and developments
5.6. CARESTREAM HEALTH
5.6.1. Operating business segments
5.6.2. Business performance
5.6.3. Key strategic moves and developments
5.7. ESAOTE S.P.A.
5.7.1. Operating business segments
5.7.2. Business performance
5.7.3. Key strategic moves and developments
5.8. HOLOGIC INC.
5.8.1. Operating business segments
5.8.2. Business performance
5.8.3. Key strategic moves and developments
5.9. SHIMADZU CORPORATION
5.9.1. Operating business segments
5.9.2. Business performance
5.9.3. Key strategic moves and developments
5.10. SAMSUNG MEDISON CO., LTD.
5.10.1. Operating business segments
5.10.2. Business performance
5.10.3. Key strategic moves and developments

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Online Only ~~$3,456~~ $3,110 Data Pack/Excel ~~$3,840~~ $3,456 Single User License ~~$5,370~~ $4,833 Five User License ~~$6,450~~ $5,805 Enterprise User License ~~$8,995~~ $8,096

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com